231277-92-2/Lapatinib

Quick Details
Molecular Formula:C29H26ClFN4O4S
Molecular Weight:581.067
Appearance:Powder
CasNo:231277-92-2

  • Product Details

    Lapatinib Good Manufacturer supply High Quality 231277-92-2

    • Molecular Formula:C29H26ClFN4O4S
    • Molecular Weight:581.067
    • Appearance/Colour:Powder 
    • Vapor Pressure:0mmHg at 25°C 
    • Refractive Index:1.645 
    • Boiling Point:750.7 °C at 760 mmHg 
    • PKA:6.34±0.19(Predicted) 
    • Flash Point:407.8 °C 
    • PSA:114.73000 
    • Density:1.381 g/cm3 
    • LogP:7.68380 

    Lapatinib (231277-92-2) Usage

    Lapatinib, a new member of the 4-anilinoquinazoline class of RTK inhibitors (RTKIs), was launched as an oral treatment for breast cancer. Lapatinib has dual affinity for EGFR and HER2 tyrosine kinases. It is indicated in combination with capecitabine for treating patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. Previously marketed drugs from the 4-anilinoquinazoline class include erlotinib (Tarceva) and gefitinib (IressaTM), both of which are indicated for treating non-small-cell lung cancer (NSCLC). As with erlotinib and gefitinib, To Market, To Market 2007 475 lapatinib is an ATP-competitive kinase inhibitor. It inhibits the tyrosine kinase activity EGFR and HER-2 with apparent Ki values of 3 and 13 nM, respectively, and has slow off-rate kinetics (t1/2X300 min). In addition, dividing the daily dose of lapatinib results in approximately 2-fold higher exposure at steady state compared to the same total dose administered once daily.The chemical synthesis of lapatinib entails the condensation of 4-chloro-6-iodoquinazoline and 3-chloro-4-(3-fluorobenzyloxy)aniline to produce a diaryl amine intermediate followed by Stille coupling of the iodo group with 5-dioxolanyl-2-(tributylstannyl)furan and subsequent acid hydrolysis of the cyclic ketal to the corresponding aldehyde. Finally, reductive amination of the aldehyde intermediate with 2-(methanesulfonyl) ethylamine in the presence of sodium triacetoxyborohydride produces lapatinib. .

    How to get the best price on Lapatinib?

    Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Lapatinib . You can buy high quality, low price Lapatinib 231277-92-2 here.

    Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.

    Milestones

    • 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
    • 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
    • 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
    • 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
    • 2023yearBusiness continues to expand, Production and Sales teams continue to grow
    • 2026yearPlans to set up foreign branches


    Hot Tags: 231277-92-2/Lapatinib, Products, API, 231277-92-2 Good Manufacturer,High Quality 231277-92-2,Good Manufacturer supply 231277-92-2
  • *Product Name
    CasNo
    Quantity
    Company Name
    *Email
    *Description
    *Code
    Items marked with * are mandatory
    Submit